A Japan-based pharmaceutical manufacturer focused on ophthalmology, developing and marketing prescription drugs and medical devices for conditions such as glaucoma, dry eye, and retinal disorders. The company generates most of its revenue in Asia and maintains a growing presence in Europe and other ...
2 members of Congress have disclosed 3 trades in Santen Pharmaceutical Co Unsponsored American Depositary Shares (SNPY), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-08-25 | Kurt Schrader | buy | $1K – $15K |
| 2010-04-06 | JAMES B. RENACCI | buy | $1,535.22 |
| 2010-01-07 | JAMES B. RENACCI | buy | $2,077.60 |